期刊
NATURE PROTOCOLS
卷 5, 期 2, 页码 294-302出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2009.223
关键词
-
资金
- National Institutes of Health [R01-CA120439]
- National Institute of General Medical Sciences [1 T32 GM070421]
- ACS Division of Medicinal Chemistry
- Ruth L. Kirschstein National Research Service Award [3F31CA130138-01S1]
- NATIONAL CANCER INSTITUTE [R01CA120439, F31CA130138] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER
this protocol describes the gram-scale solution-phase synthesis of the colorimetric caspase-3/7 substrate AC-DEVD-pNA. the caspase enzymes are integral to cellular inflammation and apoptotic cascades, and are commonly studied by cell biologists, medicinal chemists and chemical biologists. In particular, the assessment of caspase enzymatic activity is a standard method to evaluate cell death pathways and new apoptosis-modulating agents. caspase enzymatic activity can be conveniently monitored with peptidic chromogenic or fluorogenic substrates, with certain peptide sequences imparting selectivity for certain caspases. the synthesis of these peptide substrates is typically carried out by solid-phase synthesis, a method that is not ideal for production of the gram quantities needed for high-throughput screening. Described herein is a facile method for the synthesis of the Ac-DEVD-pNA caspase-3/7 substrate using solution-phase peptide synthesis. this protocol, involving iterative PyBOP-mediated couplings and Fmoc deprotections, is rapid (about 5 d), operationally simple and can be used to generate over 1 g of product at a fraction of the cost of the commercial substrate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据